Trial intelligence / Profile preview

Linaclotide plus PEG for bowel preparation before colonoscopy

ChiCTR2200064244Phase 4Not yet recruiting

Sponsor
Chongqing General Hospital
Start
Oct 2022
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of linaclotide and polyethylene glycol 3350 + electrolytes (3 arms), sponsored by Chongqing General Hospital. Primary endpoints: First defecation time, Defecation times and 4 more. Planned start Oct 2022; status: not yet recruiting.

02

Drugs

linaclotidepolyethylene glycol 3350 + electrolytes

Beyond the preview

Go deeper on ChiCTR2200064244.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200064244.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call